Psychotropic Drugs of Emerging Concerns in Aquatic Systems: Ecotoxicology and Remediation Approaches

Environmental bioremediation of pharmaceutical residues: microbial processes and technological innovations: a review

The ubiquitous presence of pharmaceuticals and personal care products (PPCPs) in the environment has become a significant concern due to their persistence, bioaccumulation potential in biota, and diverse implications for human health and wildlife. This review provides an overview of the current state-of-the-art in environmental bioremediation techniques for reducing pharmaceutical residues, with a special emphasis on microbial physiological aspects. Numerous microorganisms, including algae, bacteria or fungi, can biodegrade various pharmaceutical compounds such as antibiotics, analgesics and beta-blockers. Some microorganisms are capable of transferring electrons within the cell, and this feature can be harnessed using Bio Electrochemical Systems (BES) to potentiate the degradation of pharmaceuticals present in wastewater. Moreover, researchers are evaluating the genetic modification of microbial strains to improve their degradation capacity and expand list of target compounds. This includes also discuss how environment changes, such as fluctuations in temperature or pH, may affect bioremediation efficiency. Furthermore, the presence of pharmaceuticals in the environment is emphasised as a major public health issue because it increases the chance for antibiotic-resistant bacteria emerging. This review combines existing information and outlines needed research areas for improving bioremediation technologies in the future.

Recent occurrence of pharmaceuticals in freshwater, emerging treatment technologies, and future considerations: A review

Pharmaceuticals represent an emerging class of pollutants raising significant environmental health concerns, with their presence in freshwater systems linked to adverse aquatic ecosystem impacts and acceleration of antibiotic resistance development. This narrative review examines recent (2019-2024) pharmaceutical occurrences in freshwater globally, analyzes contamination pathways, evaluates compound-specific degradability, and assesses treatment technologies. Analysis revealed significant pharmaceutical contamination in freshwater sources across the six major continents, primarily entering through wastewater treatment plant effluents, groundwater recharge processes, and inadequate sanitation infrastructure/septic systems. Stark geographical disparities were observed, with regions lacking centralized treatment infrastructure showing multiple-fold higher concentrations, particularly in Africa and Latin America (exemplified by amoxicillin levels reaching 272,156 ng/L in Lagos, Nigeria). Pharmaceutical profiles reflected local healthcare patterns, with antimalarials and antiretrovirals prevalent in endemic regions. Globally prevalent compounds included caffeine, acetaminophen, ibuprofen, carbamazepine, sulfamethoxazole, amoxicillin, and diclofenac. While some compounds like caffeine showed relatively good removal in conventional treatment systems, their high usage rates overwhelmed treatment capacity. Others, particularly carbamazepine, demonstrated high recalcitrance to conventional treatment methods. Advanced oxidation processes and membrane technologies showed high removal efficiencies, while biochar-based systems emerged as promising, cost-effective alternatives using locally available resources. The findings underscore the need for both centralized and decentralized treatment approaches. Point-of-use technologies emerge as crucial immediate interventions for regions with inadequate infrastructure, while advanced technologies show promise for large-scale applications. The review emphasizes that municipalities should conduct systematic screening to identify locally prevalent pharmaceuticals, as treatment requirements vary significantly with local usage patterns, making a one-size-fits-all approach ineffective.

Emerging hazardous chemicals and biological pollutants in Canadian aquatic systems and remediation approaches: A comprehensive status report

Emerging contaminants can be natural or synthetic materials, as well as materials of a chemical, or biological origin; these materials are typically not controlled or monitored in the environment. Canada is home to nearly 7 % of the world's renewable water supply and a wide range of different kinds of water systems, including the Great Lake, rivers, canals, gulfs, and estuaries. Although the majority of these pollutants are present in trace amounts (μg/L - ng/L concentrations), several studies have reported their detrimental impact on both human health and the biota. In Canadian aquatic environments, concentrations of pharmaceuticals (as high as 115 μg/L), pesticides (as high as 1.95 μg/L), bioavailable heavy metals like dissolved mercury (as high as 135 ng/L), and hydrocarbon/crude oil spills (as high as 4.5 million liters) have been documented. Biological threats such as genetic materials of the contagious SARS-CoV-2 virus have been reported in the provinces of Québec, Ontario, Saskatchewan and Manitoba provinces, as well as in the Nunavut territory, with a need for more holistic research. These toxins and emerging pollutants are associated with nefarious short and long-term health effects, with the potential for bioaccumulation in the environment. Hence, this Canadian-focused report provides the footprints for water and environmental sustainability, in light of this emerging threat to the environment and society. Several remediation pathways/tools that have been explored by Canadian researchers, existing challenges and prospects are also discussed. The review concludes with preventive measures and strategies for managing the inventory of emerging contaminants in the environment.

Pharmaceutical Pollutants: Ecotoxicological Impacts and the Use of Agro-Industrial Waste for Their Removal from Aquatic Environments

Medicines are pharmaceutical substances used to treat, prevent, or relieve symptoms of different diseases in animals and humans. However, their large-scale production and use worldwide cause their release to the environment. Pharmaceutical molecules are currently considered emerging pollutants that enter water bodies due to inadequate management, affecting water quality and generating adverse effects on aquatic organisms. Hence, different alternatives for pharmaceuticals removal from water have been sought; among them, the use of agro-industrial wastes has been proposed, mainly because of its high availability and low cost. This review highlights the adverse ecotoxicological effects related to the presence of different pharmaceuticals on aquatic environments and analyzes 94 investigations, from 2012 to 2024, on the removal of 17 antibiotics, highlighting sulfamethoxazole as the most reported, as well as 6 non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac and ibuprofen, and 27 pharmaceutical drugs with different pharmacological activities. The removal of these drugs was evaluated using agro-industrial wastes such as wheat straw, mung bean husk, bagasse, bamboo, olive stones, rice straw, pinewood, rice husk, among others. On average, 60% of the agro-industrial wastes were transformed into biochar to be used as a biosorbents for pharmaceuticals removal. The diversity in experimental conditions among the removal studies makes it difficult to stablish which agro-industrial waste has the greatest removal capacity; therefore, in this review, the drug mass removal rate (DMRR) was calculated, a parameter used with comparative purposes. Almond shell-activated biochar showed the highest removal rate for antibiotics (1940 mg/g·h), while cork powder (CP) (10,420 mg/g·h) showed the highest for NSAIDs. Therefore, scientific evidence demonstrates that agro-industrial waste is a promising alternative for the removal of emerging pollutants such as pharmaceuticals substances.

Percarbonate mediated advanced oxidation of irbesartan: A suitable alternative to chlorination?

This study aims to investigate the environmental fate of irbesartan when subjected to activated percarbonate treatment. The investigation delves into the formation of disinfection byproducts (DBPs) and evaluates their toxicity, and it seeks to draw comparisons with outcomes from treatment with sodium hypochlorite, already characterized in previous findings. The proposed treatment indicates the formation of at least 11 DBPs - eight identified for the first time - which have been isolated by various chromatographic techniques, identified by Nuclear Magnetic Resonance and Mass Spectrometry studies and for which a mechanism has been proposed to elucidate their formation. To evaluate irbesartan's biological impact during treatment with sodium percarbonate (SPC), a toxicity study of the DBPs was conducted using Daphnia magna, Aliivibrio fischeri, and Raphidocelis subcapitata, three model organisms. The ecotoxicity was evaluated using the Ecological Structure-Activity Relationships (ECOSAR) computer program and compared with experimental results. Compared to chlorination treatment, a lower mineralization percentage (-43 %) and amount of DBPs at least twice higher were observed. Toxicity assessment highlighted that DBPs formed during SPC treatment were more toxic than those from chlorination. ECOSAR predicted toxicity aligned with experimental findings. Additionally, the DBPs exhibited varying levels of toxicity, primarily attributable to the presence of aromatic and hydroxyl groups in their chemical structure, indicating that SPC treatment is not suitable for treatment of irbesartan polluted waters.

Microbial degradation and transformation of PPCPs in aquatic environment: A review

The Pharmaceuticals and Personal Care Products (PPCPs) presence at harmful levels has been identified in aquatic ecosystems all over the world. Currently, PPCPs are more common in aquatic regions and have been discovered to be extremely harmful to aquatic creatures. Waste-water treatment facilities are the primary cause of PPCPs pollution in aquatic systems due to their limited treatment as well as the following the release of PPCPs. The degree of PPCPs elimination is primarily determined by the method applied for the remediation. It must be addressed in an eco-friendly manner in order to significantly improve the environmental quality or, at the very least, to prevent the spread as well as effects of toxic pollutants. However, when compared to other methods, environmentally friendly strategies (biological methods) are less expensive and require less energy. Most biological methods under aerobic conditions have been shown to degrade PPCPs effectively. Furthermore, the scientific literature indicates that with the exception of a few extremely hydrophobic substances, biological degradation by microbes is the primary process for the majority of PPCPs compounds. Hence, this review discusses about the optimistic role of microbe concerned in the degradation or transformation of PPCPs into non/less toxic form in the polluted environment. Accordingly, more number of microbial strains has been implicated in the biodegradation/transformation of harmful PPCPs through a process termed as bioremediation and their limitations.

The potential of fungi in the bioremediation of pharmaceutically active compounds: a comprehensive review

The ability of fungal species to produce a wide range of enzymes and metabolites, which act synergistically, makes them valuable tools in bioremediation, especially in the removal of pharmaceutically active compounds (PhACs) from contaminated environments. PhACs are compounds that have been specifically designed to treat or alter animal physiological conditions and they include antibiotics, analgesics, hormones, and steroids. Their detrimental effects on all life forms have become a source of public outcry due their persistent nature and their uncontrolled discharge into various wastewater effluents, hospital effluents, and surface waters. Studies have however shown that fungi have the necessary metabolic machinery to degrade PhACs in complex environments, such as soil and water, in addition they can be utilized in bioreactor systems to remove PhACs. In this regard, this review highlights fungal species with immense potential in the biodegradation of PhACs, their enzymatic arsenal as well as the probable mechanism of biodegradation. The challenges encumbering the real-time application of this promising bioremediative approach are also highlighted, as well as the areas of improvement and future perspective. In all, this paper points researchers to the fact that fungal bioremediation is a promising strategy for addressing the growing issue of pharmaceutical contamination in the environment and can help to mitigate the negative impacts on ecosystems and human health.

Advanced Polymeric Nanocomposites for Water Treatment Applications: A Holistic Perspective

Water pollution remains one of the greatest challenges in the modern era, and water treatment strategies have continually been improved to meet the increasing demand for safe water. In the last few decades, tremendous research has been carried out toward developing selective and efficient polymeric adsorbents and membranes. However, developing non-toxic, biocompatible, cost-effective, and efficient polymeric nanocomposites is still being explored. In polymer nanocomposites, nanofillers and/or nanoparticles are dispersed in polymeric matrices such as dendrimer, cellulose, resins, etc., to improve their mechanical, thermophysical, and physicochemical properties. Several techniques can be used to develop polymer nanocomposites, and the most prevalent methods include mixing, melt-mixing, in-situ polymerization, electrospinning, and selective laser sintering techniques. Emerging technologies for polymer nanocomposite development include selective laser sintering and microwave-assisted techniques, proffering solutions to aggregation challenges and other morphological defects. Available and emerging techniques aim to produce efficient, durable, and cost-effective polymer nanocomposites with uniform dispersion and minimal defects. Polymer nanocomposites are utilized as filtering membranes and adsorbents to remove chemical contaminants from aqueous media. This study covers the synthesis and usage of various polymeric nanocomposites in water treatment, as well as the major criteria that influence their performance, and highlights challenges and considerations for future research.

Adsorptive and photocatalytic remediation of hazardous organic chemical pollutants in aqueous medium: A review

The provision of clean water is still a major challenge in developing parts of the world, as emphasized by the United Nation Sustainable Development Goals (SDG 6), and has remained a subject of extensive research globally. Advancements in science and industry have resulted in a massive surge in the amount of industrial chemicals produced within the last few decades. Persistent and emerging organic pollutants are detected in aquatic environments, and conventional wastewater treatment plants have ineffectively handled these trace, bioaccumulative and toxic compounds. Therefore, we have conducted an extensive bibliometric analysis of different materials utilized to combat organic pollutants via adsorption and photocatalysis. The classes of pollutants, material synthesis, mechanisms of interaction, merits, and challenges were comprehensively discussed. The paper highlights the advantages of various materials used in the removal of hazardous pollutants from wastewater with activated carbon having the highest adsorption capacity. Dyes, pharmaceuticals, endocrine-disrupting chemicals, pesticides and other recalcitrant organic pollutants have been successfully removed at high degradation efficiencies through the photocatalytic process. The photocatalytic degradation and adsorption processes were compared by considering factors such as cost, efficiency, ease of application and reusability. This review will be good resource material for water treatment professionals/scientists, who may be interested in adsorptive and photocatalytic remediation of organic chemicals pollutants.